Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement
Clinical trial NCT03812328 · COMPLETED
Trial details
- NCT number
- NCT03812328
- Sponsor
- Tetherex Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2019-10-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.